KIM PETER S
SEC CIK 1181180 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | Dir | 104.3K | $1.37M | — | 8 | 2024-03-19 | 2024-06-03 |
Most active insiders at TRDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PARMAR KUSH | Dir, 10% | — | $3.65M |
| 2 | MPM BIOVENTURES 2018, L.P. | 10% | — | $3.60M |
| 3 | MPM BioVentures 2014, L.P. | 10% | — | $3.60M |
| 4 | 5AM Ventures V, L.P. | 10% | — | $3.00M |
| 5 | Baker Bros. Advisors (GP) LLC | 10% | $1.35M | — |
| 6 | WENTWORTH KORY JAMES | CFO | — | $433.6K |
| 7 | Dowden Nathan J | Pres, COO | — | $425.7K |
| 8 | Sethuraman Natarajan | Pres, Research, Develop | — | $398.8K |
| 9 | BAKER FELIX | 10% | $261.8K | — |
| 10 | Zeiher Bernhardt G | Dir | $29.3K | — |
KIM PETER S made no open-market trades at TRDA in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2025-06-18 | 2024-05-13+ | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $14.63 | +50.0K | 92.4K | +118% | +$731.8K |
| D | 2024-06-05 | 2024-06-03 | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | M - OptEx | $6.06 | +11.9K | 104.3K | +13% | +$72.2K |
| 2024-05-16 | 2024-05-14 | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $14.59 | +25.0K | 92.4K | +37% | +$364.8K | |
| M | 2024-05-10 | 2024-05-08+ | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $14.14 | +4,476 | 65.2K | +7% | +$63.3K |
| 2024-04-10 | 2024-04-08 | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $13.57 | +2,600 | 62.9K | +4% | +$35.3K | |
| 2024-04-01 | 2024-03-28 | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $13.75 | +1,512 | 60.3K | +3% | +$20.8K | |
| M | 2024-03-26 | 2024-03-22+ | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $13.58 | +9,048 | 56.1K | +19% | +$122.9K |
| M | 2024-03-21 | 2024-03-19+ | TRDA | Entrada Therapeutics, Inc. | KIM PETER S | Dir | P - Purchase | $12.81 | +2,732 | 49.1K | +6% | +$35.0K |
Purchase Sale Sale after option exercise All abbreviations